Digestive Disease Research Center, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
Department of Pathology, Klinikum Kulmbach, Germany.
Arch Iran Med. 2014 Jul;17(7):514-20.
Gastric cancer is a heterogeneous disorder; genetic factors, H. pylori infection and various environmental factors contribute to its development. Advanced atrophic corpus-predominant gastritis provides the histological base for its genesis. Low socio-economic status and poor hygienic conditions, smoking habits, heavy alcohol consumption, high salt and low intake of vegetables and fruits are important external factors for the occurrence of gastric cancer. For its prevention, the eradication of H. pylori infection at an early age is mandatory for subjects at high risk or those living in areas with high prevalence of gastric cancer. Given that an increased serum level of Pepsinogen II is a good biomarker for the presence of gastritis, it seems reasonable to screen all infected subjects at risk of gastric cancer with increased serum pepsinogen II at an early age (at around 30 years) to eradicate H. pylori. An endoscopy should be performed for subjects at an older age (40 years and older), when increased serum pepsinogen II level is associated with decreased serum pepsinogen I and pepsinogen I to II ratio.
胃癌是一种异质性疾病;遗传因素、幽门螺杆菌感染和各种环境因素促成其发生。晚期萎缩性胃体为主的胃炎为其发生提供了组织学基础。社会经济地位低、卫生条件差、吸烟习惯、大量饮酒、高盐和低蔬菜及水果摄入是胃癌发生的重要外在因素。为了预防胃癌,对于高危人群或胃癌高发地区的人群,应在年轻时进行幽门螺杆菌感染的根除。鉴于血清胃蛋白酶原 II 水平升高是胃炎存在的良好生物标志物,因此似乎合理的做法是,对所有有感染风险的人群进行血清胃蛋白酶原 II 筛查,以便在年轻时(约 30 岁)根除幽门螺杆菌。对于年龄较大的人群(40 岁及以上),当血清胃蛋白酶原 II 水平升高伴血清胃蛋白酶原 I 降低和胃蛋白酶原 I 与 II 比值降低时,应进行内镜检查。